Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abrupt versus step-down discontinuation of long-term PPI in stable GERD
jRCT1031180383Completed
- Start
- Aug 2019
- Countries
- 1
01
Overview
Randomised, open-label trial in gastroesophageal reflux disease (GERD) (2 arms). Primary endpoint: Withdrawal rate of PPI after 24 weeks. Started Aug 2019; status: completed.
02
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on jRCT1031180383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031180383.